^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    HiloProbe

    i
    Other names: HiloProbe
    Related tests:
    Evidence

    News

    2years
    New study confirms HiloProbe’s ColoNode kit improves colon cancer diagnostics (HiloProbe Press Release)
    "Swedish biotech company HiloProbe says it has reached a significant milestone after the results of a prospective multicenter study conducted in collaboration with Umea University and eight Swedish hospitals were published in the International Journal of Cancer. The study results show that HiloProbe’s ColoNode kit can identify more patients at risk of tumor recurrence following surgery compared to the standard method used today."
    Clinical data
    |
    ColoNode®
    over2years
    New promising ColoNode results (Mynewsdesk)
    "Umea University, has in collaboration with HiloProbe AB completed the first part of a new clinical study of its ColoNode biomarker test, which provides further important evidence for the product ColoNode’s benefits and usefulness in colon cancer."
    Licensing / partnership
    |
    ColoNode®
    over2years
    Biocartis and HiloProbe to collaborate on colorectal cancer test (Biocartis Press Release)
    "Biocartis Group NV...announce that they entered into a collaboration that will initially focus on the commercialization of ColoNode, a CE-marked IVD gene expression signature test that can help detect nodal metastasis in colorectal cancer (CRC) patients. ColoNode will be distributed as a manual kit by Biocartis to expert laboratories in selected European countries."
    Licensing / partnership
    |
    ColoNode®